Rubius Therapeutics has lured Chris Carpenter, M.D., Ph.D., away from GlaxoSmithKline to serve as its CMO. Carpenter will work as point person on Rubius’ clinical development activities as it gears up ...
Pablo Cagnoni, M.D., had a 2022 to forget. The former CEO of Flagship-founded Rubius Therapeutics spent the last quarter of the year laying off virtually all remaining staff before exiting himself, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results